Mupirocin
Bactroban and Bactroban nasal are different trade names for the same medicine.
Bactroban nasal ointment (referred to as Bactroban in this leaflet) contains the antibiotic
called mupirocin in the form of calcium mupirocin.
It is used:
This ointment is intended for use in the nose only.
If the patient is allergic to mupirocin or any of the other ingredients of Bactroban
(listed in section 6).
In case of doubts related to the use of the medicine, you should consult a doctor or pharmacist.
You should tell your doctor or pharmacist about all medicines you are currently taking or
have recently taken, including those that are available without a prescription and herbal medicines, as well as any medicines you plan to take.
If the patient is pregnant or breastfeeding, thinks she may be pregnant, or plans to have a child, she should consult her doctor or pharmacist before using this medicine.
This medicine should always be used as directed by your doctor or pharmacist. In case of doubts,
you should consult a doctor or pharmacist.
Bactroban should be inserted into the nose 2 times a day.
Instead of using the little finger to insert the medicine into the nose, you can use a cotton swab.
Special precautions should be taken with these patients. Bactroban should not be used in newborns and infants.
You should use Bactroban for as long as your doctor recommends. In case of doubts,
you should contact your doctor or pharmacist. Usually, the bacteria in the nose die
after 3-5 days of treatment.
You should not use Bactroban for more than 10 days.
If you use more Bactroban than recommended, you should contact your doctor or pharmacist.
Remove any excess ointment carefully.
If you swallow Bactroban, you should contact your doctor immediately and inform them of what and how much was swallowed.
If you forget to use Bactroban, you should use it as soon as you remember. If it is almost time for the next dose, you should skip the missed dose.
You should not use a double dose to make up for a missed dose.
If you stop using Bactroban too early, not all the bacteria may be killed or they may continue to multiply. You should ask your doctor or pharmacist when to stop using the ointment.
In case of doubts related to the use of the medicine, you should consult a doctor or pharmacist.
Like all medicines, Bactroban can cause side effects, although not everybody gets them. The following side effects may occur with Bactroban:
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 10,000 people):
In rare cases, medicines like Bactroban nasal ointment may cause colitis (inflammation of the colon) – characterized by the appearance of diarrhea, usually bloody and containing mucus, abdominal pain, fever (pseudomembranous colitis).
If you experience any of these symptoms, you should contact your doctor as soon as possible.
If you experience any side effects, including any side effects not listed in this leaflet, you should tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
By reporting side effects, you can help provide more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Store at a temperature below 25°C.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
Do not use Bactroban if it looks different from normal (see description in section 6). Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Bactroban is a white ointment with a uniform consistency. The medicine is available in tubes containing 3 g of ointment, in a cardboard box.
For more detailed information, you should contact the marketing authorization holder or parallel importer.
GlaxoSmithKline S.A.
P.T.M. C/ Severo Ochoa, 2
28760 Tres Cantos (Madrid)
Spain
GlaxoSmithKline Trading Services Limited
12 Riverwalk
Citywest Business Campus
Dublin 24
Ireland
Delpharm Poznań Spółka Akcyjna
ul. Grunwaldzka 189
60-322 Poznań
Poland
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Marketing authorization number in Spain, the country of export: 767111.4
Parallel import authorization number: 125/25
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.